Author response for "Albuminuria lowering effect of dapagliflozin, exenatide and their combination in patients with type 2 diabetes: a randomized cross‐over clinical study"Annemarie B. van der Aart‐van der Beek, Hiddo JL Heerspink, Niels Jongs et al.|Unknown|2023Cited by 0